HRS4R
Vull donar

OLGA TURA CEIDE

Firma
OLGA TURA-CEIDE
Posició
Investigador/a Consolidat - R3
Investigador/a Consolidat - R3

Projectes

Codi oficial: PI18/00960 Data inici: 01/01/2019 Data fi: 30/06/2023 Investigador/a principal: OLGA TURA CEIDE Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 159,115 €
Codi oficial: 210450 Data inici: 01/01/2022 Data fi: 31/12/2024 Investigador/a principal: ANTON OBRADOR LAGARES Organisme finançador: EUROPEAN INSTITUTE OF TECHNOLOGY Ajuda: 130,956 €
Codi oficial: PI21/01212 Data inici: 01/01/2022 Data fi: 31/12/2024 Investigador/a principal: OLGA TURA CEIDE Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 129,470 €
Codi oficial: CA18216 Data inici: 05/11/2019 Data fi: 04/11/2023 Investigador/a principal: OLGA TURA CEIDE Organisme finançador: EUROPEAN COOPERATION IN SCIENCE AND TECHNOLOGY (COST) Ajuda: 0 €
Codi oficial: 2022 FI_B 00941 Data inici: 01/06/2022 Data fi: 31/05/2025 Investigador/a principal: OLGA TURA CEIDE Organisme finançador: AGENCIA DE GESTIO D'AJUTS UNIV. I RECER. Ajuda: 69,143.51 €
Codi oficial: 1087 Data inici: 28/12/2021 Data fi: 30/06/2023 Investigador/a principal: OLGA TURA CEIDE Organisme finançador: SOC. ESP. NEUMOLOGIA Y CIRURGIA TORACICA Ajuda: 5,580 €
Codi oficial: FI22/00133 Miriam Peracaula Data inici: 01/01/2023 Data fi: 31/12/2026 Investigador/a principal: OLGA TURA CEIDE Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 119,567 €

Publicacions

0

Artificial Stone Silicosis. Progression and Laboral Impact After 3-years Follow-up.

ARCHIVOS DE BRONCONEUMOLOGIA, 2023, 59, 267-269 dx.doi.org/10.1016/j.arbres.2022.11.008

Ayyoub S, Orriols R, Oliver E, Ceide OT

Thrombosis Models: An Overview of Common In Vivo and In Vitro Models of Thrombosis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 dx.doi.org/10.3390/ijms24032569

Eichstaedt CA, Belge C, Chung WK, Gräf S, Grünig E, Montani D, Quarck R, Tenorio-Castano JA, Soubrier F, Trembath RC, Morrell NW

Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAH.

EUROPEAN RESPIRATORY JOURNAL, 2023, 61 dx.doi.org/10.1183/13993003.01471-2022
OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE OLGA TURA CEIDE
0

Editorial: Metabolic changes in vascular disorders: A path for early diagnosis and new therapeutic targets.

Frontiers In Cardiovascular Medicine, 2023, 10, 1163298-1163298 dx.doi.org/10.3389/fcvm.2023.1163298
0

Post-COVID-19 patients show an increased endothelial progenitor cell production

TRANSLATIONAL RESEARCH, 2022, 243, 14-20 dx.doi.org/10.1016/j.trsl.2022.01.004
0

Endothelial Dysfunction and Cardiovascular Risk in Obstructive Sleep Apnea: A Review Article

LIFE-BASEL, 2022, 12 dx.doi.org/10.3390/life12040537

Tura-Ceide O

Blood Flow Disturbances in Congenital Heart Disease Is Neuroblastoma Suppressor of Tumorigenicity 1 a Target for Preventing Pulmonary Vascular Remodeling?

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2022, 67, 615-616 dx.doi.org/10.1165/rcmb.2022-0368ED

Aguilar D, Bosacoma A, Blanco I, Tura-Ceide O, Serrano-Mollar A, Barberà JA, Peinado VI

Differences and Similarities between the Lung Transcriptomic Profiles of COVID-19, COPD, and IPF Patients: A Meta-Analysis Study of Pathophysiological Signaling Pathways

LIFE-BASEL, 2022, 12 dx.doi.org/10.3390/life12060887

Smolders VFED, Rodríguez C, Blanco I, Szulcek R, Timens W, Piccari L, Roger Y, Hu X, Morén C, Bonjoch C, Sebastián L, Castellà M, Osorio J, Peinado VI, Bogaard HJ, Quax PHA, Cascante M, Barberà JA, Tura-Ceide O

Metabolic profile in endothelial cells of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension

SCIENTIFIC REPORTS, 2022, 12, 2283-2283 dx.doi.org/10.1038/s41598-022-06238-z

Youssef L, Crovetto F, Simoes RV, Miranda J, Paules C, Blasco M, Palomo M, García-Calderó H, Tura-Ceide O, Dantas AP, Hernandez-Gea V, Herrero P, Canela N, Campistol JM, Garcia-Pagan JC, Diaz-Ricart M, Gratacos E, Crispi F

The Interplay between Pathophysiological Pathways in Early-Onset Severe Preeclampsia Unveiled by Metabolomics

LIFE-BASEL, 2022, 12 dx.doi.org/10.3390/life12010086

Formulari de contacte

Coneix l’IDIBGI!

menu